According to the Severe Asthma Research Program-3, inhaled corticosteroid treatment has been shown to decrease the number of ACE2 receptors and TMPRSS2 gene expression in sputum, both of which are associated with a reduced likelihood of SARS-CoV-2 entry through the airway [22,42]. The gene discussed is TMPRSS2; the disease is asthma.